ArticleNature immunology2020
An intrinsic role of IL-33 in T
Open access · greenAbstract read
In one paragraph
Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.
0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
88 citing papers in PubMed, 127 citations in OpenAlex.
- Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential.Nature reviews. Immunology · 2026Review
- The IL-33/ST2 pathway to modulate the inflammatory microenvironment: A new therapeutic target in chronic obstructive pulmonary disease.Biochemistry and biophysics reports · 2026Review
- Molecular heterogeneity and clonal origin of CCR8Nature communications · 2026Article
- Tumor heterogeneity: development, mechanisms, and therapeutic implications.Signal transduction and targeted therapy · 2026Review
- Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression.Cancer cell · 2026Article
- Regulatory T cells in cancer and inflammation.Signal transduction and targeted therapy · 2026Review
- Article
- The context-dependent role of group 2 innate lymphoid cells in lung diseases.Acta biochimica et biophysica Sinica · 2026Review
- Immune dysregulation in endometriosis: the T cell perspective.Frontiers in immunology · 2026Review
- Microglial MyD88-dependent signaling influences extracellular matrix development and interneuron maturation in the hippocampus.bioRxiv : the preprint server for biology · 2025Article
- IL-1 family cytokines in inflammation and immunity.Cellular & molecular immunology · 2025Review
- Unlocking IL-33: New Insights into Tumor Immunity.Immune network · 2025Review
- Regulatory T cells in cancer anti-PD-(L)1 therapy.Human cell · 2025Review
- FMRP silencing via siRNA lipid nanoparticles to reprogram the tumor microenvironment and enhance anti-PD-1 efficacy in triple-negative breast cancer.Materials today. Bio · 2025Article
- Article
- Review
- Insights Into Heart-Tumor Interactions in Heart Failure.Circulation research · 2025Review
- Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33.Cancer cell · 2025Article
- Circulating IL6 is involved in the infiltration of M2 macrophages and CD8+ T cells.Scientific reports · 2025Article
- Anti-PD-1 amplifies costimulation in melanoma-infiltrating TJournal for immunotherapy of cancer · 2025Article
28 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
18 authors at 11 institutions in 4 countries.
Aikaterini HatzioannouCenter of Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece.
Aggelos BanosCenter of Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece.
Theodore SakelaropoulosApplied Bioinformatics Laboratories and Department of Pathology, New York University School of Medicine, New York, NY, USA.
Constantinos FedonidisCenter of Basic Research, Biomedical Research Foundation Academy of Athens, Athens, Greece.
Maria-Sophia VidaliInstitute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, Athens, Greece.
Maren KöhneMolecular Immunology in Neurodegeneration, German Center for Neurodegenerative Diseases, Bonn, Germany.
Kristian HändlerPRECISE, Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.
Louis BoonBioceros BV, Utrecht, the Netherlands.
Ana HenriquesDepartment of Immunology, Biomedical Sciences Research Centre 'Alexander Fleming', Vari, Greece.
Vasiliki KoliarakiDepartment of Immunology, Biomedical Sciences Research Centre 'Alexander Fleming', Vari, Greece.
Panagiotis GeorgiadisInstitute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, Athens, Greece.
Jerome ZoidakisBiotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Aikaterini TermentziDepartment of Pesticides Control and Phytopharmacy, Benaki Phytopathological Institute, Athens, Greece.
Marc BeyerMolecular Immunology in Neurodegeneration, German Center for Neurodegenerative Diseases, Bonn, Germany.ORCID http://orcid.org/0000-0001-9704-148X
Triantafyllos ChavakisInstitute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-1869-5141
Dimitrios BoumpasCenter of Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece.
Aristotelis TsirigosApplied Bioinformatics Laboratories and Department of Pathology, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-7512-8477
Panayotis VerginisCenter of Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece. pverginis@bioacademy.gr.ORCID http://orcid.org/0000-0002-1282-5435
Academy of Athens · GRAlexander Fleming Biomedical Sciences Research Center · GRBiomedical Research Foundation of the Academy of Athens · GRNational Hellenic Research Foundation · GRNew York University · USUniversity of Bonn · DEBenaki Phytopathological Institute · GRGerman Cancer Research Center · DEGerman Center for Neurodegenerative Diseases · DENational and Kapodistrian University of Athens · GRPolpharma Biologics (Netherlands) · NL
Funding
European Research Council 683145European Research Council 742390
Abstract
Regulatory T (T
Indexed as
AnimalsCell Line, TumorInterferon-gammaInterleukin-1 Receptor-Like 1 ProteinInterleukin-33Melanoma, ExperimentalMiceMice, Inbred C57BLMice, KnockoutNF-kappa BT-Lymphocytes, RegulatoryTumor EscapeIl1rl1 protein, mouseIl33 protein, mouseInterferon-gammaInterleukin-1 Receptor-Like 1 ProteinInterleukin-33NF-kappa B
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.